Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Isopaque Cerebral
2. Isopaque Coronar
3. Meglumine Calcium Metrizoate
4. Methylglucamine Metrizoate
5. Methylglucamine Metrizoate Calcium
6. Sodium Meglumine Calcium Metrizoate
1. Metrizoate Meglumine
2. Isopaque Cerebral
3. Rjy6jr42wq
4. 7241-11-4
5. Isopaque Coronar
6. Unii-rjy6jr42wq
7. Metrizoate De Methylglucamine
8. Schembl1237977
9. Chembl1200353
10. Einecs 230-641-3
11. Meglumine Metrizoate [mart.]
12. Meglumine Metrizoate [who-dd]
13. Metrizoate De Methylglucamine [french]
14. 1-deoxy-1-(methylamino)-d-glucitol 3-(acetylamino)-5-(acetyl Methylamino)-2,4,6-triiodobenzoate(salt) Mixt. With 3-(acetylamino)-5-(acetylmethylamino)-2,4,6,- Triiodobenzoic Acid Calcium Salt (2:1)
15. Meglumine Metrizoate [orange Book]
16. Q27288154
17. 1-deoxy-1-(methylamino)-d-glucitol 3-(acetylamino)-5-(acetylmethylamino)-2,4,6-triiodobenzoate
18. 3-acetamido-5-[acetyl(methyl)amino]-2,4,6-triiodobenzoic Acid;(2r,3r,4r,5s)-6-(methylamino)hexane-1,2,3,4,5-pentol
19. Benzoic Acid, 3-(acetylamino)-5-(acetylmethylamino)-2,4,6-triiodo-, Compd. With D-glucitol, 1-deoxy-1-(methylamino)- (1:1)
20. D-glucitol, 1-deoxy-1-(methylamino)-, 3-acetamido-5-(n-methylacetamido)-2,4,6-triiodobenzoate (salt)
| Molecular Weight | 823.2 g/mol |
|---|---|
| Molecular Formula | C19H28I3N3O9 |
| Hydrogen Bond Donor Count | 8 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 9 |
| Exact Mass | 822.8960 g/mol |
| Monoisotopic Mass | 822.8960 g/mol |
| Topological Polar Surface Area | 200 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 582 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
84
PharmaCompass offers a list of Methylglucamine Metrizoate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Methylglucamine Metrizoate manufacturer or Methylglucamine Metrizoate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Methylglucamine Metrizoate manufacturer or Methylglucamine Metrizoate supplier.
PharmaCompass also assists you with knowing the Methylglucamine Metrizoate API Price utilized in the formulation of products. Methylglucamine Metrizoate API Price is not always fixed or binding as the Methylglucamine Metrizoate Price is obtained through a variety of data sources. The Methylglucamine Metrizoate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Methylglucamine Metrizoate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Methylglucamine Metrizoate, including repackagers and relabelers. The FDA regulates Methylglucamine Metrizoate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Methylglucamine Metrizoate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Methylglucamine Metrizoate supplier is an individual or a company that provides Methylglucamine Metrizoate active pharmaceutical ingredient (API) or Methylglucamine Metrizoate finished formulations upon request. The Methylglucamine Metrizoate suppliers may include Methylglucamine Metrizoate API manufacturers, exporters, distributors and traders.
Methylglucamine Metrizoate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Methylglucamine Metrizoate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Methylglucamine Metrizoate GMP manufacturer or Methylglucamine Metrizoate GMP API supplier for your needs.
A Methylglucamine Metrizoate CoA (Certificate of Analysis) is a formal document that attests to Methylglucamine Metrizoate's compliance with Methylglucamine Metrizoate specifications and serves as a tool for batch-level quality control.
Methylglucamine Metrizoate CoA mostly includes findings from lab analyses of a specific batch. For each Methylglucamine Metrizoate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Methylglucamine Metrizoate may be tested according to a variety of international standards, such as European Pharmacopoeia (Methylglucamine Metrizoate EP), Methylglucamine Metrizoate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Methylglucamine Metrizoate USP).
